Short answer
Bank7 Corp. (BSVN) filed an 8-K current report with the SEC on October 15, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Third-quarter 2026 results covered quarter ended September 30, 2026.
Bank7 Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Third-quarter 2026 results covered quarter ended September 30, 2026
- Earnings press release attached as Exhibit 99.1, with operating and financial details
- Conference call scheduled October 15, 2026 at 9:00 a.m. CST
- Investor presentation attached as Exhibit 99.2 for additional management commentary
- Disclosure furnished under Reg FD, not deemed filed under Exchange Act Section 18
Item EX-99.1 · Exhibit EX-99.1
- Q3 net income $10.20M, up 22.25% sequentially, with diluted EPS $1.06 versus $0.87
- Assets reached $2.01B and loans $1.63B, up 4.84% and 2.22% from Q2
- Net interest margin fell to 4.77% from 5.07% year over year, despite lower deposit costs
- Capital remained strong: Bank total risk-based ratio 16.31%, well above regulatory minimums
- Century Financial merger received approvals and shareholder approval, with closing expected November 1, 2026
Item EX-99.2 · Exhibit EX-99.2
- Q3 EPS $1.06, core EPS $1.11, with ROATCE 15.60% and core ROATCE 16.50%
- NIM excluding loan fees 4.38%, supporting resilient earnings through varying interest-rate cycles
- Century Financial acquisition valued at approximately $137 million, adding roughly $1.2 billion of deposits
- Closing expected November 1, 2026, with projected EPS accretion exceeding 25% and combined assets near $3.3 billion
- Credit metrics remain strong: nonperforming assets 0.45% of loans, net charge-offs 4 basis points, ACL/NPLs 260.80%
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Bank7 Corp. 8-K filings
Get the next BSVN 8-K as it lands
Follow BSVN for push alerts, or ask the research agent what this filing means.